Multiple studies have revealed that combined radiotherapy and immunotherapy can be more effective at overcoming tumor immunosuppression and increasing the incidence of abscopal effect compared to RT alone, regardless of the type of immune checkpoint inhibitor combined with either CTLA-4 or PD-1/PD-L1 inhibitors (13, 14). The gene discussed is PDCD1; the disease is neoplasm.